VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma.
Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma. Cancer Res. 2007 Nov 15; 67(22):10976-83.
View in:
PubMed
subject areas
Animals
Cell Line, Tumor
Cell Proliferation
Enzyme Inhibitors
Female
Focal Adhesion Protein-Tyrosine Kinases
Humans
Inhibitory Concentration 50
Mice
Mice, Nude
Morpholines
Neoplasm Transplantation
Neovascularization, Pathologic
Ovarian Neoplasms
Platelet Endothelial Cell Adhesion Molecule-1
Proliferating Cell Nuclear Antigen
authors with profiles
GABRIEL LOPEZ
ANIL K SOOD